FNY Investment Advisers’s Cabaletta Bio CABA Stock Holding History

FNY Investment Advisers’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23K	Buy	+7,500	New	+$24.7K	0.01%	514
2023 Q1	–	Sell	-200	Closed	-$1K	–	579
2022 Q4	$1K	Buy	+200	New	+$728	﹤0.01%	437

Other funds holding CABA

MATAURO New York $756M AUM 20.74% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

FNY Investment Advisers's CABA Position: Q2 2026 in Review

FNY Investment Advisers opened a new position in Cabaletta Bio (CABA) in Q2 2026: 7,500 shares worth $23K. The stake represents 0.01% of the portfolio and ranks #514 among its holdings. This is a return to the name: FNY Investment Advisers previously reported a position in CABA as recently as Q4 2022.

FNY Investment Advisers first reported a position in CABA in Q4 2022 and has held it in 2 quarters since. 6 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

FNY Investment Advisers held 7,500 shares of Cabaletta Bio worth $23K as of Q2 2026.
Cabaletta Bio was a new FNY Investment Advisers position in Q2 2026.
Cabaletta Bio made up 0.01% of FNY Investment Advisers's portfolio in Q2 2026, its #514 holding.
FNY Investment Advisers first reported a position in Cabaletta Bio in Q4 2022 and has held it in 2 quarters since.
6 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.